Analysis evaluates willingness-to-pay for QALY in malignant tumors, suggesting implications for healthcare funding decisions.
This paper evaluated the monetary value of QALY among people with malignancies in China. Our analysis reveals an inverse relationship between national income levels and the ratio of WTP per QALY to GDP per capita, suggesting that lower-income countries may adopt relatively higher cost-utility thresholds in proportion to their GDP per capita. Additionally, the ratios of WTP/QALY to GDP per capita for patients with malignant tumors are similar to those of the general population with life-threatening conditions; patients with non-life-threatening diseases have comparable WTP/QALY to GDP per capita ratios with the general population in a quality-of-life improvement scenario, providing empirical reference for decision-making and resource allocation in the stratified disease management. Future studies with more representative samples across a broader range of countries are warranted to enable a more comprehensive and systematic discussion.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: